Drugs / AG-707
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00231049 | Mar 2006 → ? | genital herpes simplex type 2 infectious disorder | Agenus Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AG-707 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00231049 ↗ |
| Modality | Vaccine | “AG-707 vaccination” NCT00231049 ↗ |